Form 4: Director Eric Palmer Acquires LifeStance Health Stock

Director Eric Palmer of LifeStance Health Group, Inc. acquired 17,746 restricted stock units on July 2, 2026.

Summary

• Director Eric P. Palmer acquired 17,746 restricted stock units (RSUs) in LifeStance Health Group, Inc. on July 2, 2026.
• These RSUs represent a contingent right to receive one share of the Issuer's common stock.
• Following this transaction, Mr. Palmer beneficially owns 89,174 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard RSU grant to a director rather than an open market purchase or sale, which would provide stronger signals.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 17,746 RSUs indicates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of RSUs by a director, are common in the healthcare services sector as a form of executive compensation and alignment with shareholder interests.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting insider confidence in the company's value.

Key Dates

Keywords

LifeStance Health, LFST, Form 4, Insider Transaction, Restricted Stock Units, Director Acquisition, Beneficial Ownership